Caribou Biosciences, Inc. (CRBU)

1.62 +0.07 (+4.52%) USD  |  NASDAQ  |  Feb 18, 16:00
1.62 0.00 (0.00%) After-Hours: 17:30
More

Caribou Biosciences Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for CRBU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
SELLAS Life Sciences Group, Inc. Upgrade
GT Biopharma, Inc. --
Aclaris Therapeutics, Inc. Upgrade
Nurix Therapeutics, Inc. Upgrade
Lyell Immunopharma, Inc. Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade
Profit Margin (Quarterly) Upgrade
Gross Profit Margin (Quarterly) Upgrade
Operating Margin (Quarterly) Upgrade